Wikidata

(Q62105309)

English

Campath-1H + FK506 and Methylprednisolone for GVHD

clinical trial

In more languages

Statements

title
Phase II Clinical Trial Incorporating Alemtuzumab (Campath-1H) in Combination With FK506 and Methylprednisolone for Treatment of Severe Acute Graft vs Host Disease (English)
0 references
medical condition
lymphoma
0 references
syndrome
0 references
leukemia
0 references
multiple myeloma
0 references
neuroblastoma
0 references
plasmacytoma
0 references
start time
January 2005
0 references
end time
June 2006
0 references
number of participants
34
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62105309&oldid=1857052336"